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Abstract
Background: Most cases of hepatitis B virus (HBV) infection and subsequent liver diseases can be prevented with
universal newborn HBV vaccination. The attitudes of health care workers about HBV vaccination and their
willingness to recommend vaccine have been shown to impact HBV vaccination coverage and the prevention of
vertical transmission of HBV. The purpose of this study was to ascertain the factors associated with health care
worker recommendations regarding newborn HBV vaccination.
Methods: A cross-sectional study of prevalence and awareness of hepatitis B and hepatitis B vaccine was
conducted among randomly selected physicians and nurses employed in seven hospitals in Georgia in 2006 and
2007. Self-administered questionnaires included a module on recommendations for HBV, HCV and HIV.
Results: Of the 1328 participants included in this analysis, 36% reported recommending against hepatitis B
vaccination for children, including 33% of paediatricians. Among the 70.6% who provided a reason for not
recommending HBV vaccine, the most common concern was an adverse vaccine event. Unvaccinated physicians
and nurses were more likely to recommend against HBV vaccine (40.4% vs 11.4%, PR 3.54; 95% CI: 2.38, 5.29).
Additionally, health care worker age was inversely correlated with recommendations for HBV vaccine with older
workers less likely to recommend it.
Conclusion: Vaccinating health care workers against HBV may provide a dual benefit by boosting occupational
safety as well as strengthening universal coverage programs for newborns.
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Background
Hepatitis B virus (HBV) infection remains a major global
public health concern. Georgia is among the countries
with an intermediate prevalence of chronic HBV infec-
tion (2.7%), similar to that of other Eastern European
and Central Asian countries [1-3]. The risk of hepatitis
due to vertical transmission or from exposure in early
childhood (e.g., medical exposure to contaminated
equipment, household transmission, child-to-child trans-
mission) is of particular concern because infection at a
young age is associated with a substantial increased risk
of liver disease (e.g., cirrhosis, hepatocellular carcinoma)
later in life [4,5].
Fortunately, HBV is preventable through hepatitis B
vaccination. The vaccine has been shown to be safe and
efficacious for newborns and children [6,7]. Countries
which have implemented universal newborn HBV vac-
cination have reported substantial declines in HBV inci-
dence that is associated with these increases in
vaccination coverage [8,9]. Thus, most cases of HBV and
its sequelae could be prevented by a universal newborn
HBV vaccination program. The success of such public
health initiatives depends largely on the degree to which
health care providers promote vaccination.
Despite the availability of free vaccine for newborns in
Georgia, anecdotal information suggested that health
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care worker (HCW) concerns about the safety of the
HBV vaccine posed an important challenge to universal
vaccine coverage for newborns [10]. The study con-
ducted among 297 HCWs reported that only 54% of
study participants would recommend the vaccine to
other HCWs. Perception of vaccine safety was identified
as the most important predictor for acceptance
(Prevalence Ratio (PR)=3.25 [95% CI:1.19, 8.90]) and for
willingness to recommend HBV vaccine to their
colleagues [11].
While neonatologists and pediatricians are responsible
for newborn HBV vaccinations, HCWs of other special-
ties likely have a significant indirect impact on vaccine
coverage in the general population. Georgians, like those
of every culture, also seek advice for health-related deci-
sions from relatives or friends, some of whom may be
physicians and nurses. This form of education may
supersede the advice of physicians who are known only
through a transient patient-provider relationship. Thus,
the casual dialogue about HBV vaccination shared by
HCWs among acquaintances, friends and family, and ac-
cordingly, their willingness to advise vaccination, may
affect HBV vaccination coverage among the most vul-
nerable population—newborns.
The purpose of this study was to identify factors asso-
ciated with HCWs recommendations for newborn HBV
vaccination. The hypothesis was that HCWs who were
not vaccinated, and thus had no personal experience
with the vaccine, would be more likely to recommend
against HBV vaccination of newborns.
Methods
Study design and sample
A cross-sectional study on the prevalence and awareness
of HBV and other infections was conducted among ran-
domly selected physicians and nurses employed in seven
Georgian hospitals between January 1, 2006 and Decem-
ber 31, 2007. Self-administered questionnaires included
a module on recommendations for HBV vaccine for
newborns. These physicians were also underwent sero-
logical testing for HBV, HCV and HIV.
Seven major hospitals located in five cities were
chosen to be representative of Georgia, including three
from Tbilisi, the capital and largest city, two from West-
ern Georgia and two from Eastern Georgia. Study parti-
cipants were selected using simple random sampling of
physicians and nurses of selected departments based on
lists provided by the hospitals of all full-time employees.
The departments enlisted for the study included internal
medicine, obstetrics, surgery, intensive care, dialysis and
paediatrics. Enrolment continued until the designated
number (proportional to number of HCWs per hospital)
was met.
Enrollment and data collection
Potential study participants were invited to voluntarily
participate during a private interview with a researcher.
The study, including the content of the questionnaire
and testing for HBV, HCV and HIV were explained and
informed consent was obtained. To maintain confidenti-
ality, a study code was provided to each HCW and the
code was used to label questionnaires and blood sam-
ples. Furthermore, a study physician provided test results
to all participants along with counselling and referral
when further tests were needed. Approval by both Geor-
gian and US Ethics Committees was obtained prior to
initiation of the study.
The questionnaire was pilot tested in a small group of
physicians and nurses and modified prior to the study.
Formative evaluation of the questionnaire was con-
ducted using qualitative methods to assess clarity of the
questions. The questionnaire included demographic,
clinical and occupational characteristics and knowledge,
attitudes, and practices requiring exposure to, and pro-
tection from, blood-borne pathogens. The HCWs' will-
ingness to recommend HBV vaccine to newborns was
assessed by the question: “Would you advise HBV vac-
cine for newborns?” Factors hypothesized to be asso-
ciated with recommending HBV vaccine for newborns
were included in the analyses, including self-reported
history of HBV vaccination, fear of vaccine-related side
effects, misconceptions of vaccine effectiveness, demo-
graphic characteristics (e.g., age, gender), clinical charac-
teristics (e.g., immune status to HBV and HCV) and
occupational characteristics (e.g., job category), position
(e.g., physicians, nurses), and risky occupational behav-
iour (e.g., accidental needle-sticks and blood splashes).
Laboratory analysis
Venous blood (2–3 ml) was drawn from health care
workers and transported daily from the hospitals to the
laboratory in Tbilisi for storage and analysis. To deter-
mine HBV infection status, third generation ELISA tests
(manufacturer Orgenics, Israel) were used for HBsAg
and anti-HBc. All HBsAg-positive samples were further
investigated by confirmatory assays, with immunoreac-
tion of neutralization combined with HBsAg.
Statistical analysis
Data were checked for quality, double-entered into SPSS
(Version 13.0) and verified, before analysis using SPSS
and SAS (Version 9.2). Bivariate analyses were per-
formed to assess the association between a history of
being vaccinated and each potential predictive factor as
well as willingness to advise vaccination for newborns.
Multivariate analysis was conducted using Poisson re-
gression with robust variance estimators to identify the
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variable most predictive of recommending HBV vaccine
to newborns.
Results
Of the 1600 randomly selected HCWs, 1386 (86%) en-
rolled in the study and 1328 (83%) provided sufficient
information for inclusion in the analysis (Answered the
question: Would you recommend HBV vaccine to chil-
dren?). Of these 1328 HCWs, 22.80% were 35 years of
age or younger; 20.86% were males. The study partici-
pants were from a broad range of specialties, including
surgery (28.60%), internal medicine (19.58%), intensive
care (18.45%), obstetrics-gynaecologists (15.44%), dialysis
(6.93%), paediatricians (6.63%) and others (4.14%).
46.76% of respondents were physicians, 28.40% were
from the age group of 35 or younger. 387 HCWs
(29.14%) had HBc antibodies and 26 (1.96%) were
HBsAg positive.
Overall, 478 (36%) study participants reported recom-
mending against HBV vaccination for children. Of the
279 who reported a specific reason, the most common
was concern about an adverse vaccine event (38%, 111/
279) followed by belief that the vaccine was not effective
(23%, 64/279).
Based on the bivariate analysis, the strongest correlate
for likelihood of recommending HBV vaccination was
the HCW’s own vaccination status. Unvaccinated HCWs
were much more likely to recommend against HBV vac-
cine than their vaccinated colleagues (40.40% vs 11.40%,
respectively, prevalence ratio (PR) = 3.54; 95% CI: 2.38,
5.29). Age was also a factor, with older HCWs more
likely to recommend against HBV vaccine compared to
those younger than age 35 (39.20% vs 28.40%, respect-
ively). There was no substantive difference between the
recommendations for physicians compared to nurses. A
third of paediatricians recommended against HBV vac-
cine, similar to other HCWs. Dialysis HCWs were the
most likely to recommend vaccination, with only 10.9%
(PR=3.03; 95% CI: 1.58, 5.85) recommending against it.
By multivariate analysis, the only significant predictor of
recommending HBV vaccine for newborns was the
HCW’s own vaccination status (Table 1).
Factors related to vaccination status
Age group was significantly associated with vaccination
status: HCWs younger than 35 were more likely to be
vaccinated compared to older colleagues (22.80% vs
12.30%, PR=1.85; 95% CI:1.42, 2.43). There was no sta-
tistically significant difference in the prevalence of anti-
HBc in vaccinated and unvaccinated persons (28.10%
anti-HBc positives among vaccinated versus 29.40%
among unvaccinated HCWs). In the subgroup of HCWs
35 years or younger, the prevalence of anti-HBc was
20% among vaccinated persons as compared to 24.20%
among unvaccinated HCWs (difference not significant).
Gender, occupation and history of occupational exposure
to patient’s blood (blood splash, needle-stick, cut with
contaminated instrument) were not associated with HBV
vaccination.
Discussion
As in other countries [10,12], concerns about vaccine
safety persist in Georgia among the general population
as well as among HCWs. What may be unique to this
country is a pervasive and persistent concern that trans-
cends the safety data for this vaccine. While HBV vac-
cine has an excellent safety and efficacy record [13-17],
perceptions in Georgia have been affected by general
concerns about vaccine safety and effectiveness and spe-
cifically by one highly publicized neurologic event that
occurred a week after an HBV vaccination in Georgia
[10]. Overcoming these misconceptions to develop a
strong and sustainable universal vaccination program is
crucial to reduce HBV in newborns and children and
help eliminate HBV- associated liver disease and the
economic burden of this disease for Georgia.
This study found that 36% of HCWs did not recom-
mend HBV vaccination for newborns. Only two groups
of HCWs appeared to be importantly different: dialysis
workers who see the impact of HBV among their
patients at very high risk of the infection, and HCWs
who are vaccinated against HBV. However, as evidence
of the intractable nature of vaccine safety concerns, one
in every ten of these HCWs would also recommend
against HBV vaccine for newborns. Age correlated with
vaccine status, with older HCWs being the least likely to
be vaccinated and least likely to recommend vaccine.
These findings provide insight into the demographics of
concern about vaccine safety and inform the develop-
ment of potential interventions to improve knowledge
about HBV vaccination.
There was no statistically significant difference in the
prevalence of anti-HBc in vaccinated and unvaccinated
persons. This could be probably explained by the fact
that during the HCW’s HBV vaccination campaign in
2001 there was no HBV antibody testing conducted
prior to HBV vaccination and those being already HBV
infected without knowing it received the vaccine.
During the study period over 80% of HCWs were not
yet vaccinated against HBV. While this finding is similar
to many developing countries [18-20], it is the polar op-
posite of most developed countries where the majority
of HCWs are vaccinated [21-24]. These unvaccinated
HCWs are substantially less likely to recommend vac-
cine to newborns. Fear of adverse events and lack of
knowledge regarding vaccine efficacy are major factors
affecting many HCWs recommendations and personal
health practices. While these issues may be addressed by
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educational programs, the specific experiences of this
population suggest educational programs alone are in-
sufficient. Targeted programs which specifically address
the publicized event and shed light on the facts may help
assuage some concerns.
Personal experience with HBV vaccine appears to be
associated with recommending vaccine to newborns.
Having received HBV vaccine is associated with a
healthcare worker recommending the vaccine to new-
borns. The reasons a healthcare worker might receive
the vaccine may be complex. Yet access to the vaccine
may be a key factor. If the vaccine is available to the
HCW and the barrier of cost is removed, it seems likely
that the HCW may consider the personal cost-benefit
relationship in a different context. They ultimately may
see the benefits of the vaccine as more favourable, re-
ceive the vaccine and ultimately be more likely to rec-
ommend HBV vaccination for newborns as well as
others.
Vaccination programs for HCWs can be justified
based on their occupational risk of infection. Cost is
always a factor in any vaccine initiative. Some hospi-
tals in a neighbouring country, Turkey, have screened
HCWs upon employment and identified those suscep-
tible to HBV for vaccination. This screening and vaccine
program is cost-effective given the relatively large pro-
portion of HCWs that have already been exposed to
HBV. In Georgia, approximately 30% of HCWs have
evidence of prior HBV exposure and thus would not
directly benefit from the vaccine. The remaining HCWs
would benefit from the vaccine and safety data sug-
gests that those HCWs who were already vaccinated
would not be harmed by revaccination (essentially an
additional booster) [25,26]. This last point is important
because one significant barrier to a screening program
is the potential harm caused by employers identify-
ing HCWs who are infectious. Thus, creating an ac-
cessible national program for HCW vaccination must
rely on a confidential screening program, or universal
vaccination for those with an unreliable vaccination
history.
Cost-effectiveness studies on HBV vaccine pro-
grams for HCWs typically focus on the occupational
risks of HBV infection and benefit of the vaccine to pro-
tect HCWs and patients [27,28]. This study suggests
increasing the proportion of HCWs vaccinated for HBV
may increase vaccination coverage of newborns and
children.
This study had a strong sampling design and benefited
from laboratory testing to establish exposure to HBV.
Like all studies, it also had limitations. The primary limi-
tation is that all other information was self-reported.
Based on the results, there does not appear to be sub-
stantial bias due to social desirability as the proportion
of HCWs recommending vaccine is relatively low. An-
other limitation is that participation was not 100%. It is






Recommending against HBV vaccine for
children No. (%)
Bivariate Prevalence Ratio
(PR) and 95% CI
Adjusted Prevalence Ratio
(aPR) and 95% CI
Self reported vaccination status
Unvaccinated 1120 453 (40.40) 1.00 1.00
Vaccinated 193 22 (11.40) 3.54 (2.38, 5.29) 1.45 (1.18,1.72)
Missing values 15
Age group
>35 931 365 (39.20) 1.00 1.00
<=35 303 86 (28.40) 0.72 (0.59,0.88) 0.89 (0.71,1.05)
Missing values 94
Gender
Female 1050 386 (36.80) 1.00 1.00
Male 277 92 (33.20) 0.90 (0.75, 1.09) 0.89 (0.72,1.09)
Missing values 1
Position
Physician 621 234 (37.70) 1.00 1.00
Nurse 700 243 (34.70) 0.92 (0.79,1.06) 0.95 (0.89,1.12)
Missing values 7
Department
Paediatrics 88 29 (33.00) 1.00 1.00
Surgery 381 133 (34.90) 1.06 (0.76,1.47) 1.08 (0.79,1.63)
Dialysis 92 10 (10.90) 3.03 (1.58,5.85) 0.83 (0.58,1.19)
ICU 245 103 (42.00) 1.27 (0.91,1.78) 1.19 (0.86,1.67)
Internal medicine 260 102 (39.20) 1.19 (0.85,1.66) 1.12 (0.81,1.54)
Obstetrician – 205 78 (38.00) 1.15 (0.82,1.63) 1.09 (0.78,1.52)
Gynecologist
Lab 55 21(38.20) 1.16 (0.74,1.81) 1.00 (0.63,1.59)
Missing values 2
Butsashvili et al. BMC Infectious Diseases 2012, 12:362 Page 4 of 6
http://www.biomedcentral.com/1471-2334/12/362
possible that HCWs with active disease were more likely
to refuse participation. However, this would not alter the
overall conclusions.
The prevalence of HBV infection (anti-HBc) among
study participants was about 29%, higher than the preva-
lence among the general population in Georgia (20%)
[29]. This difference could be explained by the occupa-
tional exposure to HBV among HCWs. Even if the ma-
jority of HCWs are not likely to develop significant liver
disease sequelae if infected later in life, they can transmit
the virus to patients and household members who have
not been vaccinated. Thus, it would be useful to assess
cost-effectiveness of screening for both HBV antibodies
prior to vaccinating susceptibles and universal vaccin-
ation for HCWs in the absence of screening. In either
case, cost-effectiveness analyses of HBV vaccination pro-
grams for HCWs should broaden their assessment of
benefits.
In 2009 the Ministry of Labour, Health, and Social
Affairs of Georgia and the National Center for Diseases
Control established a hepatitis B catch-up vaccination
program for at-risk healthcare workers, medical stu-
dents, and adolescents in three regions of the country:
Tbilisi (capital city with 1/3 of Georgia population),
Imereti and Adjara (regions in western Georgia) with
support of Rostropovich-Vishnevskaya Foundation.
By 2010, 12,963 health care workers have been
screened for hepatitis B (Anti-HBc) and 4,579 (35.3%)
appeared to be Anti-HBc(+). The rest of HCWs were
offered administration of HBV vaccine on a voluntary
basis, from which 7,000 have been vaccinated against
hepatitis B.
No study was conducted to estimate the impact of
vaccination campaign among HCWs on the attitude of
HCWs towards HBV vaccine and their willingness to
recommend it to the children.
Conclusion
Our study reinforced the importance of HBV vaccination
among HCWs for the obvious direct occupational bene-
fits such protection confers as well as possibly recom-
mending vaccination for newborns. This study leads us
to recommend the education and outreach targeted to-
wards HCWs who are least likely to perceive the benefits
of HBV vaccination; those over age 35, may improve the
long-term HBV vaccine prevalence rates. Such programs
must also remove barriers to vaccination such as con-
cern for social consequences and personal financial
burden.
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